Literature DB >> 26721303

Fibromatosis of the Sigmoid Colon With CTNNB1 (β-Catenin) Gene Mutation, Arising at the Site of Ileocolic Anastomosis for Resection of Gastrointestinal Stromal Tumor.

Khin Thway1, Sara Abou Sherif2, Angela M Riddell2, Satvinder Mudan2.   

Abstract

We describe a case of intra-abdominal fibromatosis, which occurred in a 44-year-old woman who had a previous history of gastrointestinal stromal tumor (GIST) of the sigmoid mesocolon, which was treated with imatinib and resection. A mass was detected at the site of ileocolic anastomosis of the previous small bowel resection and sigmoid colectomy, nearly 3 years later. Clinically, this was suspected to represent recurrent GIST and was excised, but histology and mutational analysis showed desmoid-type fibromatosis with a mutation in codon 41 of exon 3 of the CTNNB1 (β-catenin) gene. The occurrence of fibromatosis at the site of excision of GIST is very rare, but its recognition is important as the treatment of the two neoplasms differs significantly. As imaging cannot reliably distinguish between these 2 entities, histological diagnosis is crucial for correct clinical management.
© The Author(s) 2015.

Entities:  

Keywords:  CTNNB1 (β-catenin) gene; anastomosis; fibromatosis; gastrointestinal stromal tumor; large bowel; molecular; mutational analysis; post surgery; sarcoma; sigmoid colon; small bowel; soft tissue

Mesh:

Substances:

Year:  2015        PMID: 26721303     DOI: 10.1177/1066896915620012

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  2 in total

1.  Mesenteric fibromatosis after resection for gastrointestinal stromal tumor of stomach: A case report.

Authors:  Yiming Chu; Qingqu Guo; Dan Wu
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

2.  Successful treatment of giant mesenteric fibromatosis with surgery and tamoxifen: case report.

Authors:  Zhixiang Jin; Qi Zhang; Dong Tang; Liuhua Wang; Wei Wang; Minghao Xu; Zhi Li; Daorong Wang
Journal:  Transl Cancer Res       Date:  2019-06       Impact factor: 1.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.